Dr. Yukun Wang | Bioinformatics – Southern University of Science and Technology | China
Profile Verified
📚 Education & Experience
Professor Yukun Wang, born in June 1965 in Qiqihar, Heilongjiang, holds a Ph.D. in Epidemiology and Health Statistics from the Fourth Military Medical University, where he also earned his bachelor’s and master’s degrees. With over 35 years of experience in military medical education, clinical pharmacy, and healthcare management, he currently serves as Vice President of the Affiliated Hospital and Professor at the School of Medicine, Southern University of Science and Technology (SUSTech). Previously, he held key leadership roles including Dean of the School of Pharmacy and Director of Discipline Construction at the Fourth Military Medical University. His international experience spans Belgium, Hong Kong, the U.S., and the U.K., allowing him to incorporate global medical education practices into Chinese healthcare. He holds the military rank of Senior Colonel (大校).
✅ Suitability Summary
Professor Wang’s diverse background in clinical medicine, pharmacy education, and international collaboration positions him as a leading expert in medical education reform and pharmaceutical research. His expertise bridges statistical modeling, clinical trial design, hospital administration, and education policy. He excels in integrating precision medicine, drug safety, and big data analytics into modern teaching and healthcare systems, making him highly suited for strategic leadership roles.
📈 Professional Development
Professor Wang plays an active role in numerous national academic committees. He is a Standing Member of the National Pharmacy Education Committee, Chair of the Clinical Pharmacy Committee (China Association for Maternal and Child Health), and Chair of the Shenzhen Pharmacology Society. He serves as Vice Chair on the Textbook Expert Committee for pharmacy and is part of the National Pharmacy Accreditation Group. Additionally, he has contributed to national education planning, pharmaceutical policy, and traditional Chinese medicine (TCM) innovation.
🔬 Research Focus
Professor Wang’s research spans health statistics, clinical pharmacy, and translational medicine. He developed the CISS (Comprehensive Injury Severity Score) system tailored for Chinese trauma patients and has applied Delphi methods, ROC curves, and logistic regression in medical evaluations. His research on mRNA methylation, tumor resistance, and drug delivery systems using nanoparticles has contributed to new directions in cancer therapy. In clinical trials, he focuses on sample size optimization, data imputation, and sequential design methods. His studies on pharmaceutical economics, drug accessibility, and price-quality regulation in TCM support national policy innovations. He also explores precision pharmacy, rational drug use, maternal-infant drug safety, and drug shortages.
🏆 Honors & Awards
Professor Wang has received a Third-Class Military Merit, and multiple honors for excellence in teaching, scientific research, and graduate education. His accolades include the First Prize in Higher Education Research (China Higher Education Society, 2013) and Second Prizes in Shaanxi Provincial Teaching Achievements (2012, 2014). At the institutional level, he has been named Outstanding Party Member, Advanced Educator, and contributor to the “211 Project”. His recognized work in discipline development, education reform, and pharmaceutical regulation reflects his deep impact on both academic and healthcare sectors.
📚 Selected Publication
Identification of m6A-modified gene signatures in lung adenocarcinoma tumorigenesis and their potential role in drug resistance
-
Authors: Han Xiaomin, Ma Qiang, Chang Ruyi, Wang Ruilong, Wang Yukun
-
Journal: Discover Oncology
-
Year: 2025
2. Long non-coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway
-
Authors: Bao Han, Guo Chun-Guang, Qiu Peng-Cheng, Zhang Xin-Lei, Dong Qi, Wang Yu-Kun*
-
Journal: Oncology Letters
-
Year: 2017
3. Combined experimental and theoretical insight into the drug delivery of nanoporous metal-organic frameworks
-
Authors: Jiaping Wang, Juncheng Jin, Fumei Li, Baohong Li*, Jianqiang Liu, Jie Jin, Chunfeng Wang, Zengyong Qing*, Yukun Wang*
-
Journal: RSC Advances
-
Year: Not explicitly given, but likely 2024 or 2025 based on context (please confirm if needed)
4. Synthesis of a Novel Nitronyl Nitroxide Radical and Determination of its Protective Effects Against Infrasound-Induced Injury
-
Authors: Wang H. B., Wang J., Yang Q., Zhang X. W., Gao P., Xu S. L., Sun X. L., Wang Y. K.
-
Journal: Neurochemical Research
-
Year: 2015
5. Selective in vivo and in vitro activities of 3,3′-4-nitrobenzylidene-bis-4-hydroxycoumarin against methicillin-resistant Staphylococcus aureus by inhibition of DNA polymerase III
-
Authors: Hou Z., Zhou Y., Li J., Zhang X., Shi X., Xue X., Li Z., Ma B., Wang Y., Li M., Luo X.
-
Journal: Scientific Reports
-
Year: 2015